Walid Kutayli, MD
Clinical Cardiac Electrophysiology · Lincoln, NENPI 1346321981
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 53.2% of the total. Reporting peaked in 2022 at $6,945 and has fallen 89.5% since, to $730 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NE, where the typical reported total is $23,571.
Across 322 payments — averaging $39.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Biosense Webster, Inc.$2K
- Abbott$1K
- Stereotaxis Inc$940
- Boston Scientific$837
- Philips North America LLC$116
- plus $342 from 9 others
Across 23 payments — averaging $1342.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$31K
What the payments were for
- Consulting fees$2,85022%
- Travel & lodging$3,61428%
- Food & beverage$6,40350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 63 | $6,839 |
| Biosense Webster, Inc. | 185 | $2,328 |
| Abbott | 18 | $1,465 |
| Stereotaxis Inc | 8 | $940 |
| Boston Scientific | 18 | $837 |
| Philips North America LLC | 5 | $116 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $88 |
| Volta Medical Inc | 1 | $58 |
| Edwards Lifesciences | 2 | $42 |
| Johnson & Johnson | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Cardiofocus, Inc. | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Pfizer | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$1,090
- Niobe$813
- AZURE XT DR MRI SURESCAN$379
- NUVISION ICE CATHETER$267
- Carto 3$248
- AURORA EV-ICD MRI SURESCAN$175
- QDOT MICRO$120
- Connect HF$114
- Rhythmia Mapping System$111
- CLARIA MRI QUAD CRT-D SURESCAN$104
- WATCHMAN FLX$102
How this compares
$12,867 in reported general payments places this provider in the 35th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
See all clinical cardiac electrophysiology providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 385 | $274,349 |
| XareltoRivaroxaban | 338 | $254,096 |
| MultaqDronedarone Hcl | 24 | $28,038 |
| Flecainide Acetate | 137 | $5,075 |
| Metoprolol Succinate | 259 | $3,524 |
| Amiodarone Hcl | 108 | $2,814 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $2,169 |
| Nebivolol Hcl | 28 | $1,773 |
| Mexiletine Hcl | 20 | $1,344 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 74 | $1,299 |
| Propafenone Hcl | 17 | $913 |
| Bisoprolol Fumarate | 56 | $893 |
| ClopidogrelClopidogrel Bisulfate | 80 | $793 |
| Cephalexin | 76 | $323 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $308 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $274,349385 claims |
| Johnson & JohnsonXarelto | $31 | $254,096338 claims |
| Sanofi-aventis U.S. LLCMultaq | $31 | $28,03824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
Other clinical cardiac electrophysiology in Lincoln
- Grant WallaceLincoln$59K
- Peter GallagherLincoln$48K
- Stephen AckermanLincoln$45K
- Andrew MerlissLincoln$158
- Brian KimKearney$455K
- Hussam AbuissaOmaha$162K
- Jeffrey MahoneyOmaha$118K
- Shane TsaiOmaha$68K
- Jason PayneOmaha$59K
- Matthew SorensenOmaha$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.